transthyretin protein binding antibodies (Prothena)

N/A

Report date: 2025/03/20 09:37:47

Base Information

Drug Nametransthyretin protein binding antibodies (Prothena)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTransthyretin modulators
TargetsTransthyretin
Therapy Area/IndicationsAmyloid Neuropathies, Familial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProthena Corp Plc
China Registration ClassN/A

Develop Information

Active CompaniesProthena Corp Plc
Inactive CompaniesN/A
Active IndicationsAmyloid Neuropathies, Familial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A